Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis

Stefanos Giannopoulos(Denver VA Medical Center), Ehrin J. Armstrong(University of Denver), Omar Jawaid(Denver VA Medical Center), T. Raymond Foley(Lancaster General Hospital), Prio Hossain(University of California, Davis), Gagan D. Singh(University of California, Davis), Bejan Alvandi(University of Utah), Stephen W. Waldo(United States Department of Veterans Affairs), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Sean Behan(Denver VA Medical Center)
Cardiovascular revascularization medicine
October 18, 2019
10.1016/j.carrev.2019.10.006
Cited by 16

Related Papers

Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
|Cancer Prevention Research|2009|193